FTC sues significant pharmacy advantage managers around insulin selling prices The agency introduced action towards Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the listing cost of lifestyle-saving insulin drugs. UnitedHealth sues CMS over Medicare Advantage star rankings A handful of plans owned https://labelthefigurewiththeitem38382.blog5.net/73130796/about-healthcare-news